These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25412911)

  • 1. [The HAROW study: an example of outcomes research: a prospective, non-interventional study comparing treatment options in localized prostate cancer].
    Herden J; Ernstmann N; Schnell D; Weißbach L
    Urologe A; 2014 Dec; 53(12):1743-52. PubMed ID: 25412911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Treatment of Localized Prostate Cancer in Everyday Practice in Germany.
    Herden J; Ansmann L; Ernstmann N; Schnell D; Weißbac L
    Dtsch Arztebl Int; 2016 May; 113(19):329-36. PubMed ID: 27232362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment mapping of prostate cancer in DVPZ prostate centers in Germany].
    Berges R; Ebert T; Schafhauser W; Schultze-Seemann W; Braun M; Herden J; Weib P; Garcia Schürmann M; Reimann M; Bornhof C; Oberpenning F; Baur P; Zumbé J; Gronau E; Diederichs W; Brinkman OA; Goepel M; Göll A; Hoefner K; Kriegmair M; Laabs S; Planz B; Platz G; Heidenreich A
    Urologe A; 2015 Nov; 54(11):1546, 1548-54. PubMed ID: 26518302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment costs of localized prostate cancer in Germany : Economic results from the HAROW observational study].
    Reinhold T; Dornquast C; Börgermann C; Weißbach L
    Urologe A; 2016 Dec; 55(12):1573-1585. PubMed ID: 27822603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Implementation of the S3 prostate cancer guideline in daily clinical practice: results of a survey among urologists].
    Fröhner M; Khan C; Koch R; Schorr SG; Wirth M
    Urologe A; 2014 Oct; 53(10):1500-3. PubMed ID: 24984950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elderly prostate cancer patients: patient information and shared decision making].
    Ernstmann N; Jaeger J; Kowalski C; Pfaff H; Weißbach L
    Urologe A; 2013 Jun; 52(6):847-52. PubMed ID: 23328778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patterns of care of patients with localized prostate cancer in Germany: a health care study with focus on active surveillance].
    Chun FK; Becker A; Kluth LA; Seiler D; Schnell D; Fisch M; Graefen M; Weissbach L
    Urologe A; 2015 Jan; 54(1):6-13. PubMed ID: 25391440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["Expanded prostate cancer index composite" (EPIC-26): Results of functional treatment in patients with localized prostate cancer].
    Beyer B; Huland H; Feick G; Graefen M
    Urologe A; 2015 Nov; 54(11):1591-5. PubMed ID: 26347350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.
    Herden J; Eminaga O; Wille S; Weissbach L
    Urol Int; 2015; 95(2):209-15. PubMed ID: 26044747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HAROW: the first comprehensive prospective observational study comparing treatment options in localized prostate cancer.
    Weissbach L; Stuerzebecher S; Mumperow E; Klotz T; Schnell D
    World J Urol; 2016 May; 34(5):641-7. PubMed ID: 26373955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification: a tool to predict the course of active surveillance for localized prostate cancer?
    Herden J; Heidenreich A; Weissbach L
    BJU Int; 2017 Aug; 120(2):212-218. PubMed ID: 27862832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative assessment of active surveillance for localized prostate cancer in the community versus tertiary care referral center.
    Becker A; Seiler D; Kwiatkowski M; Kluth LA; Schnell D; Graefen M; Schlomm T; Fisch M; Recker F; Weissbach L; Chun FK
    World J Urol; 2014 Aug; 32(4):891-7. PubMed ID: 24820259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active surveillance in localized prostate cancer: comparison of incidental tumours (T1a/b) and tumours diagnosed by core needle biopsy (T1c/T2a): results from the HAROW study.
    Herden J; Wille S; Weissbach L
    BJU Int; 2016 Aug; 118(2):258-63. PubMed ID: 26332209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment quality of prostate cancer centers. Analysis of the 2014 annual report of the German Cancer Society].
    Kälble T; Fichtner J
    Urologe A; 2015 Nov; 54(11):1523-4, 1526-9. PubMed ID: 26573669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of follow-up in melanoma patients in Germany - results of a multicentre and longitudinal study.
    Livingstone E; Krajewski C; Eigentler TK; Windemuth-Kieselbach C; Benson S; Elsenbruch S; Hauschild A; Rompel R; Meiss F; Mauerer A; Kähler KC; Dippel E; Möllenhoff K; Kilian K; Mohr P; Utikal J; Schadendorf D
    Eur J Cancer; 2015 Mar; 51(5):653-67. PubMed ID: 25638778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Searching for clues].
    Steffens JA
    Urologe A; 2010 Aug; 49(8):907-9. PubMed ID: 20652678
    [No Abstract]   [Full Text] [Related]  

  • 17. A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer.
    Ernstmann N; Ommen O; Kowalski C; Neumann M; Visser A; Pfaff H; Weissbach L
    Support Care Cancer; 2012 Apr; 20(4):791-7. PubMed ID: 21479989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Certified prostate centers of the DVPZ : Current status].
    Zumbe J; Berges R
    Urologe A; 2010 Aug; 49(8):916-21. PubMed ID: 20652675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specialist uro-oncological rehabilitation after treatment for prostate cancer--update 2015. Position statement of the working group on "rehabilitation of urological and nephrological diseases" of the German Society of Urology with respect to current S3 guidelines].
    Müller G; Otto U; Vahlensieck W; Zermann DH
    Urologe A; 2015 Aug; 54(8):1108-14. PubMed ID: 26246209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
    Cooperberg MR; Lin DW; Morgan TM; Chapin BF; Chen RC; Eggener SE
    J Urol; 2022 Feb; 207(2):262-264. PubMed ID: 34775795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.